New Key Statistics Module, Z-Score and F-Score
OTCPK:GLAXF Key Ratios
| Market Cap $ M | 104,865.52 |
| Enterprise Value $ M | 127,365.03 |
| P/E(ttm) | 13.77 |
| PE Ratio without NRI | 13.77 |
| Forward PE Ratio | 11.09 |
| Price/Book | 4.42 |
| Price/Sales | 2.45 |
| Price/Free Cash Flow | 16.89 |
| Price/Owner Earnings | 16.45 |
| Payout Ratio % | 0.46 |
| Revenue (TTM) $ M | 44,094.00 |
| EPS (TTM) $ | 1.92 |
| Beneish M-Score | -2.43 |
| 10-y EBITDA Growth Rate % | 0.90 |
| 5-y EBITDA Growth Rate % | 3.60 |
| y-y EBITDA Growth Rate % | 37.70 |
| EV-to-EBIT | 11.53 |
| EV-to-EBITDA | 8.94 |
| PEG | 3.83 |
| Shares Outstanding M | 4,005.60 |
| Net Margin (%) | 17.78 |
| Operating Margin % | 25.67 |
| Pre-tax Margin (%) | 22.69 |
| Quick Ratio | 0.52 |
| Current Ratio | 0.79 |
| ROA % (ttm) | 9.55 |
| ROE % (ttm) | 36.74 |
| ROIC % (ttm) | 14.03 |
| Dividend Yield % | 3.38 |
| Altman Z-Score | 2.15 |
GLAXF Number of Guru Trades
GLAXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:GLAXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GLAXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GSK PLC Insider Transactions
No Available Data
News about OTCPK:GLAXF
Total 0- 1